Atlas Trials

Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2

Clinical trial NCT00400374 · COMPLETED

Trial details

NCT number
NCT00400374
Sponsor
Emory University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Head and Neck Cancer
Start date
2007-08-01
Primary completion
2012-12-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.